IL231403A0 - Thiazolopyridine compounds as a10pde inhibitors - Google Patents
Thiazolopyridine compounds as a10pde inhibitorsInfo
- Publication number
- IL231403A0 IL231403A0 IL231403A IL23140314A IL231403A0 IL 231403 A0 IL231403 A0 IL 231403A0 IL 231403 A IL231403 A IL 231403A IL 23140314 A IL23140314 A IL 23140314A IL 231403 A0 IL231403 A0 IL 231403A0
- Authority
- IL
- Israel
- Prior art keywords
- pde10a inhibitors
- triazolopyridine compounds
- triazolopyridine
- compounds
- pde10a
- Prior art date
Links
- 229940123773 Phosphodiesterase 10A inhibitor Drugs 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11181752 | 2011-09-19 | ||
| PCT/EP2012/068203 WO2013041472A1 (en) | 2011-09-19 | 2012-09-17 | Triazolopyridine compounds as pde10a inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL231403A0 true IL231403A0 (en) | 2014-04-30 |
Family
ID=46851999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL231403A IL231403A0 (en) | 2011-09-19 | 2014-03-06 | Thiazolopyridine compounds as a10pde inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8946427B2 (enExample) |
| EP (1) | EP2758396B1 (enExample) |
| JP (1) | JP2014526533A (enExample) |
| KR (1) | KR101584925B1 (enExample) |
| CN (1) | CN103827114B (enExample) |
| AU (1) | AU2012311713A1 (enExample) |
| BR (1) | BR112014006248A2 (enExample) |
| CA (1) | CA2846758C (enExample) |
| CL (1) | CL2014000641A1 (enExample) |
| CO (1) | CO6900144A2 (enExample) |
| EA (1) | EA201490599A1 (enExample) |
| ES (1) | ES2626801T3 (enExample) |
| IL (1) | IL231403A0 (enExample) |
| MX (1) | MX2014003025A (enExample) |
| PE (1) | PE20141553A1 (enExample) |
| PH (1) | PH12014500499A1 (enExample) |
| SG (1) | SG11201400759RA (enExample) |
| UA (1) | UA108711C2 (enExample) |
| WO (1) | WO2013041472A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2757882B1 (en) | 2011-09-22 | 2020-11-04 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
| EP2757883B1 (en) | 2011-09-22 | 2021-01-13 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
| DK2991984T3 (en) | 2013-04-30 | 2017-05-08 | Hoffmann La Roche | PALLADIUM-CATALYST COUPLING OF PYRAZOLAMIDES |
| TWI652014B (zh) | 2013-09-13 | 2019-03-01 | 美商艾佛艾姆希公司 | 雜環取代之雙環唑殺蟲劑 |
| CA2956268A1 (en) * | 2014-07-30 | 2016-02-04 | Mochida Pharmaceutical Co., Ltd. | Pyrazole derivative manufacturing method |
| CA2956262A1 (en) * | 2014-07-30 | 2016-02-04 | Mochida Pharmaceutical Co., Ltd. | Pyrazole derivative manufacturing method |
| CN112679467B (zh) | 2015-03-11 | 2024-11-01 | Fmc公司 | 杂环取代的二环唑杀有害生物剂 |
| BR112017019326B1 (pt) | 2015-03-12 | 2022-04-26 | Fmc Corporation | Composto, composição e método para controlar uma praga invertebrada |
| EP3359545B1 (en) | 2015-10-08 | 2024-03-20 | FMC Corporation | Heterocycle-substituted bicyclic azole pesticides |
| ES2932627T3 (es) * | 2017-08-22 | 2023-01-23 | Bayer Ag | Derivados heterocíclicos como pesticidas |
| EP3978077B1 (en) | 2019-05-27 | 2023-11-29 | Nihon Nohyaku Co., Ltd. | Condensed heterocyclic compound having a bridgehead nitrogen atom or salt thereof, agricultural or horticultural insecticide comprising the compound, and method for using the insecticide |
| AR119140A1 (es) | 2019-06-13 | 2021-11-24 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
| CN110396157B (zh) * | 2019-08-07 | 2021-07-30 | 广州市建筑科学研究院有限公司 | 缓释型聚羧酸纳米减水剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| WO2005012485A2 (en) | 2003-07-31 | 2005-02-10 | Bayer Pharmaceuticals Corporation | Methods for treating diabetes and related disorders using pde10a inhibitors |
| NL2000397C2 (nl) * | 2006-01-05 | 2007-10-30 | Pfizer Prod Inc | Bicyclische heteroarylverbindingen als PDE10 inhibitoren. |
| WO2010035745A1 (ja) * | 2008-09-25 | 2010-04-01 | 杏林製薬株式会社 | ヘテロ環ビアリール誘導体及びそれらを有効成分とするｐｄｅ阻害剤 |
| WO2010059836A1 (en) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
| US8685967B2 (en) * | 2009-04-07 | 2014-04-01 | Merck Sharp & Dohme Corp. | Substituted triazolopyridines and analogs thereof |
| HRP20150345T1 (hr) * | 2009-09-24 | 2015-05-08 | F. Hoffmann-La Roche Ag | Derivati imidazopiridina ili imidazopirimidina kao inhibitori fosfodiesteraze 10a |
| WO2011063830A1 (en) | 2009-11-24 | 2011-06-03 | Nokia Corporation | An apparatus |
| TWI485151B (zh) * | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TWI487705B (zh) * | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
| TW201200516A (en) * | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
-
2012
- 2012-09-17 PE PE2014000366A patent/PE20141553A1/es not_active Application Discontinuation
- 2012-09-17 PH PH1/2014/500499A patent/PH12014500499A1/en unknown
- 2012-09-17 AU AU2012311713A patent/AU2012311713A1/en not_active Abandoned
- 2012-09-17 BR BR112014006248A patent/BR112014006248A2/pt not_active IP Right Cessation
- 2012-09-17 SG SG11201400759RA patent/SG11201400759RA/en unknown
- 2012-09-17 CA CA2846758A patent/CA2846758C/en not_active Expired - Fee Related
- 2012-09-17 KR KR1020147009588A patent/KR101584925B1/ko not_active Expired - Fee Related
- 2012-09-17 EP EP12759445.5A patent/EP2758396B1/en not_active Not-in-force
- 2012-09-17 UA UAA201404029A patent/UA108711C2/uk unknown
- 2012-09-17 JP JP2014531187A patent/JP2014526533A/ja active Pending
- 2012-09-17 EA EA201490599A patent/EA201490599A1/ru unknown
- 2012-09-17 WO PCT/EP2012/068203 patent/WO2013041472A1/en not_active Ceased
- 2012-09-17 MX MX2014003025A patent/MX2014003025A/es active IP Right Grant
- 2012-09-17 CN CN201280045398.XA patent/CN103827114B/zh not_active Expired - Fee Related
- 2012-09-17 ES ES12759445.5T patent/ES2626801T3/es active Active
-
2014
- 2014-03-05 CO CO14047250A patent/CO6900144A2/es unknown
- 2014-03-06 IL IL231403A patent/IL231403A0/en unknown
- 2014-03-17 CL CL2014000641A patent/CL2014000641A1/es unknown
- 2014-03-18 US US14/218,275 patent/US8946427B2/en not_active Expired - Fee Related
- 2014-12-16 US US14/572,312 patent/US9227970B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| UA108711C2 (uk) | 2015-05-25 |
| US20140303141A1 (en) | 2014-10-09 |
| US9227970B2 (en) | 2016-01-05 |
| PH12014500499A1 (en) | 2014-04-14 |
| KR20140075716A (ko) | 2014-06-19 |
| CN103827114B (zh) | 2016-08-24 |
| CL2014000641A1 (es) | 2014-11-14 |
| CN103827114A (zh) | 2014-05-28 |
| CA2846758C (en) | 2017-09-12 |
| EP2758396A1 (en) | 2014-07-30 |
| SG11201400759RA (en) | 2014-07-30 |
| US8946427B2 (en) | 2015-02-03 |
| EP2758396B1 (en) | 2017-03-29 |
| WO2013041472A1 (en) | 2013-03-28 |
| BR112014006248A2 (pt) | 2017-04-11 |
| CA2846758A1 (en) | 2013-03-28 |
| ES2626801T3 (es) | 2017-07-26 |
| CO6900144A2 (es) | 2014-03-20 |
| NZ621597A (en) | 2015-04-24 |
| EA201490599A1 (ru) | 2014-07-30 |
| KR101584925B1 (ko) | 2016-01-12 |
| AU2012311713A1 (en) | 2014-03-13 |
| PE20141553A1 (es) | 2014-10-30 |
| JP2014526533A (ja) | 2014-10-06 |
| MX2014003025A (es) | 2014-05-28 |
| US20150099735A1 (en) | 2015-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284539A (en) | Heterocycloamines as PI3K inhibitors | |
| ZA201306997B (en) | Triazolopyridine compounds as pim kinase inhibitors | |
| PL2716642T3 (pl) | Związki imidazopirydyny | |
| IL231403A0 (en) | Thiazolopyridine compounds as a10pde inhibitors | |
| AP3529A (en) | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors | |
| ZA201400374B (en) | 4-piperidinyl compounds for use as tankyrase inhibitors | |
| IL228103A0 (en) | Amino-quinolines as kinase inhibitors | |
| ZA201303811B (en) | Triazolopyridine compounds | |
| IL235829A0 (en) | Triazolo compounds as pde10 inhibitors | |
| ZA201308697B (en) | Hydroxymethylaryl-substituted pyprolotriazines as alk1 inhibitors | |
| GB201120474D0 (en) | Inhibitors |